Athero Review - Issue 1/2024

Editorial

3
Editorial

Guidelines

7
Consensus statement of the European Atherosclerosis Society on the 2022 lipoprotein(a) – responses to the frequently asked questions about these recommendations

Lukáš Zlatohlávek, Vladimír Bláha, Renata Cífková, Tomáš Freiberger, David Karásek, Pavel Kraml, Jan Piťha, Hana Rosolová, Vladimír Soška, Tomáš Štulc, Michal Vrablík Za Výbor Čsat, Jana Mašková


Reviews

19
PCSK9 inhibitors (temporarily) in the broad practice of outpatient specialists: short but positive experience

Michal Vrablík

27
First clinical experience with inclisiran in Slovakia – experience with administration, management and efficacy from one center

Štefan Tóth, Patrik Buček, Richard David, Matej Šajty

35
News from pre-specified subgroup analyzes of the CLEAR-Outcomes trial

Ubomíra Fábryová

42
I am 55 years old, my cholesterol is 6.5 mmol/l and I do not want statin

Jan Piťha, Michal Vrablík


Personal News

41
Professor Hana Rosolová jubilating

47
Semaglutide confirms its position in cardiovascular prevention in the SELECT study

Michal Vrablík


From International Literature

49
Research on remarkable articles from international literature

Eva Tůmová


Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account